APOL1,α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia

Haematologica

Volumn 102, Issue 1, 2017, Pages e1-e6

  Saraf, Santosh L ^a   Shah, Binal N ^a   Zhang, Xu ^a   Han, Jin ^a   Tayo, Bamidele O ^b   Abbasi, Taimur ^a   Ostrower, Adam ^a   Guzman, Elizabeth ^a   Molokie, Robert E ^a   Gowhari, Michel ^a   Hassan, Johara ^a   Jain, Shivi ^a   Cooper, Richard S ^b   Machado, Roberto F ^a   Lash, James P ^a   Gordeuk, Victor R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN; APOLIPOPROTEIN L1; B CELL LYMPHOMA LEUKEMIA 11A PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN F; HYDROXYUREA; PROTEIN; UNCLASSIFIED DRUG; APOL1 PROTEIN, HUMAN; BCL11A PROTEIN, HUMAN; CARRIER PROTEIN; NUCLEAR PROTEIN;

ADULT; AGE; ALBUMIN TO CREATININE RATIO; ALBUMINURIA; ALPHA THALASSEMIA; CHRONIC KIDNEY DISEASE; DNA POLYMORPHISM; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC RISK; HEMOGLOBINURIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; RENAL SYSTEM PARAMETERS; RISK FACTOR; SICKLE CELL ANEMIA; CHRONIC KIDNEY FAILURE; COMPLICATION; GENETICS;

ADULT; ALPHA-THALASSEMIA; ANEMIA, SICKLE CELL; APOLIPOPROTEIN L1; CARRIER PROTEINS; FEMALE; HUMANS; MALE; NUCLEAR PROTEINS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 85008400995     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2016.154153     Document Type: Letter

References (14)

1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-487.
2. Saraf SL, Zhang X, Kanias T, et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol. 2014;164(5):729-739.
3. Darbari DS, Wang Z, Kwak M, et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013;8(11):e79923.
4. Parsa A, Kao WH, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013;369(23):2183-2196.
5. Ashley-Koch AE, Okocha EC, Garrett ME, et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol. 2011;155(3):386-394.
6. Saraf SL, Zhang X, Shah B, et al. Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica. 2015;100(10):1275-1284.
7. Higgs DR, Aldridge BE, Lamb J, et al. The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med. 1982;306(24):1441-1446.
8. Guasch A, Zayas CF, Eckman JR, Muralidharan K, Zhang W, Elsas LJ. Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. J Am Soc Nephrol. 1999;10(5):1014-1019.
9. Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342(6155):253-257.
10. Sheehan VA, Luo Z, Flanagan JM, et al. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol. 2013;88(7):571-576.
11. Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A. 2008;105(33):11869-11874.
12. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.
13. Haymann JP, Stankovic K, Levy P, et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin J Am Soc Nephrol. 2010;5(5):756-761.
14. Kidd JL, Azimi M, Lubin B, Vichinsky E, Hoppe C. Application of an expanded multiplex genotyping assay for the simultaneous detection of Hemoglobin Constant Spring and common deletional alpha-thalassemia mutations. Int J Lab Hematol. 2010;32(4):373-380.